Results 101 to 110 of about 788,607 (367)

NOACs versus warfarin for stroke prevention in patients with AF : a systematic review and meta-analysis [PDF]

, 2016
Acknowledgments Revman software was used for meta-analysis, a free download from the Cochrane Collaboration. GRADE pro software was used to formulate the GRADE summary of findings table, a free download from the GRADE working group.Peer reviewedPublisher
Eisinga, Anne, Hicks, Tim, Stewart, Fiona   +2 more
core   +1 more source

Cis‐Chelating Diphosphanes for Intra‐Cavity Nickel(II)‐Catalyzed Ethylene Oligomerization

Chemistry – A European Journal, Accepted Article.
Four cis‐chelating diphosphanes derived from cyclodextrins (CDs), each with various intra‐cavity environments, compel NiII or PdII metal centers to reside within α‐ or β‐CD cavities. Nickel(II) complexes of these metal‐confining ligands act as active catalysts in ethylene oligomerization upon activation with modified methyaluminoxane (MMAO).
Yang Li, Sara Figueirêdo de Alcântara Morais, Mingyang Han, Tuan-Anh Phan, Geordie Creste, Matthieu Jouffroy, Dominique Matt, Jean-Pierre Djukic, Yann Cornaton, Pierre Braunstein, Katrin Pelzer, Dominique Armspach   +11 more
wiley   +1 more source

Is There an Alternative Oral Anticoagulation to Vitamin-K-Antagonists for Patients with Mechanical Aortic Valve Replacement? – A Literature Review

Cardiology and Therapy
Current guidelines exclusively recommend vitamin-K-antagonists (VKA) as anticoagulation for patients after mechanical aortic valve replacement due to the increased postoperative risk of valve thrombosis and thrombo-embolism.
Stephen Gerfer, Thorsten Wahlers, Elmar Kuhn   +2 more
doaj   +1 more source

Direct oral anticoagulants and venous thromboembolism [PDF]

, 2016
Venous thromboembolism (VTE), consisting of deep vein thrombosis and pulmonary embolism, is a major clinical concern associated with significant morbidity and mortality.
Massimo Franchini, Pier Mannuccio Mannucci   +1 more
core   +3 more sources

Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.

Cochrane Database of Systematic Reviews, 2015
BACKGROUND Deep vein thrombosis (DVT) is a condition in which a clot forms in the deep veins, most commonly of the leg. It occurs in approximately 1 in 1,000 people.
L. Robertson, P. Kesteven, J. McCaslin
semanticscholar   +1 more source

Effects of a single subcutaneous dose of enoxaparin on veterinary viscoelastic coagulation monitor variables in healthy cats: Double blind, placebo controlled cross‐over trial

Journal of Veterinary Internal Medicine, Volume 37, Issue 1, Page 133-139, January/February 2023., 2023
Abstract Background Cats placed on anticoagulant medication require frequent monitoring. The veterinary viscoelastic coagulation monitor (VCM‐Vet) could provide a convenient and cost‐effective monitoring, enabling therapeutic decision making. Hypothesis/Objectives Enoxaparin will lead to changes in VCM‐Vet variables and these will correlate with antiXa
Ivayla D. Yozova, Michael S. Kent, Karl E. Jandrey   +2 more
wiley   +1 more source

Revealing timescale-dependent oxygen vacancy distributions in solid oxide fuel cell electrodes using frequency-resolved X-ray absorption (FR-XAS) [PDF]

arXiv, 2022
Development of materials for electrochemical energy conversion requires a deep understanding of the factors governing chemical and physical rates at submicron length scales. Many workers have sought to develop chemically sensitive in situ or operando imaging techniques targeting these length scales.
arxiv  

Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden

Clinical Epidemiology, 2020
Marie Linder,1 Anastasia Iliadou Nyman,2,3 Helle Kieler,1 Bengt Danielsson,2 Natalia Borg,2 Marcus Gry,2 Julius Collin2 1Centre for Pharmacoepidemiology, Karolinska Institutet, T2, Karolinska University Hospital, Stockholm, Sweden; 2The National Board of
Linder M, Iliadou Nyman A, Kieler H, Danielsson B, Borg N, Gry M, Collin J   +6 more
doaj  

Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy. [PDF]

, 2017
We present the case of a patient with a deep vein thrombosis (DVT) who failed rivaroxaban therapy. Our patient initially presented with left lower extremity edema, erythema, and pain.
Adashek, Jacob, Ben-Zur, Uri M, Nagar, Menachem, Pietras, Richard J, Toomari, Nojan, Yaghoubian, Jonathan M, Yaghoubian-Yazi, Bahareh   +6 more
core   +5 more sources

Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase

Clinical Pharmacology &Therapeutics, EarlyView.
Apixaban could be a potential treatment option for the prevention of venous thromboembolism (VTE) in children with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL). This analysis describes an updated two‐compartment population pharmacokinetic (PPK) model that characterizes the PK variability of apixaban in pediatric patients with ALL ...
Praneeth Jarugula, Toni Ajavon‐Hartmann, Obinna Obianom, Elizabeth Ludwig, Christina Crevar, David Marchisin, Zhaoqing Wang, Weidong Chen, Bing He, Lesley G. Mitchell, Vilmarie Rodriguez, Glen Lew, Vidya Perera, Bindu Murthy, Samira Merali   +14 more
wiley   +1 more source